We are representing hundreds of metal-on-metal hip implant patients who allegedly suffered serious complications, including metallosis and premature device failure, due to these devices.
New York, New York (PRWEB) April 19, 2013
Bernstein Liebhard LLP notes that the Consumers Union has called on the U.S. Food & Drug Administration (FDA) to subject metal-on-metal hip implants to greater regulatory scrutiny. Specifically, the group sent a Comment Letter to the FDA on April 18th urging the agency to adopt its proposed rule requiring metal hip implants to be reviewed through the premarket approval (PMA) process. Currently metal-on-metal hip replacements are permitted to be approved via the FDA’s 510(k) clearance system, which does not require a medical device to undergo human clinical trials. According to the Consumers Union, the letter to the FDA has been signed by more than 11,000 consumers.*
“We are representing hundreds of metal-on-metal hip implant patients who allegedly suffered serious complications, including metallosis and premature device failure, due to these devices. We applaud the efforts of Consumers Union to address the current regulation of metal-on-metal hips,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to alleged victims of metal-on-metal hip replacement devices.
Metal-on-Metal Hip Implant Lawsuits
The FDA has been investigating metal-on-metal hip replacements since February 2011, amid concerns that metal ions shed from the hips can result in metallosis, adverse local tissue reactions, and early failure of the device. In January, the agency issued new guidance for patients fitted with metal-on-metal hip replacements, advising doctors to consider metal ion testing in those experiencing symptoms of hip implant failure. The FDA also said it had proposed a new rule that would make all-metal hips ineligible for 510(k) approvals.**
Numerous metal hip implant manufacturers are currently named in lawsuits involving these devices. Bernstein Liebhard LLP is actively filing complaints associated with the 2010 DePuy ASR hip recall in a multidistrict litigation underway in U.S. District Court, Northern District of Ohio. According to court records, the first trials in that litigation are to begin this spring. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197) Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committee for a second multidistrict litigation established in U.S. District Court, Northern District of Texas for metal-on-metal DePuy Pinnacle hip replacement lawsuits. (In re: DePuy Orthopaedics, Inc. Pinnacle Hip Implant Products Liability Litigation - MDL No. 2244)
The Firm is also actively filing claims in a multidistrict litigation for Biomet hip replacement lawsuits that is currently underway in U.S. District Court, Northern District of Indiana (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391), and in the consolidated litigation underway in New Jersey Superior Court for claims involving the Stryker Rejuvenate hip recall. (In re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)
Alleged victims of metal-on-metal hip replacements may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. A wealth of information about filing a metal-on-metal hip implant lawsuit is available on Bernstein Liebhard LLP’s website. For additional information, please contact one of our attorneys by calling 877-779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP